MIG
XLRN

Mariner Investment Group’s Acceleron Pharma XLRN Stock Holding History

Mariner Investment Group’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-27,700
Closed -$941K – 130
2016
Q2 		$941K Sell
27,700
-2,300
-8% -$74.8K 0.32% 82
2016
Q1 		$792K Buy
30,000
+5,200
+21% +$151K 0.22% 102
2015
Q4 		$1.21M Hold
24,800
– – 0.27% 112
2015
Q3 		$618K Hold
24,800
– – 0.12% 142
2015
Q2 		$785K Buy
+24,800
New +$800K 0.2% 117

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Mariner Investment Group's XLRN Position: Q3 2016 in Review

Mariner Investment Group sold out of Acceleron Pharma (XLRN) in Q3 2016, closing a stake of 27,700 shares — an estimated $941K sold.

Mariner Investment Group first reported a position in XLRN in Q2 2015 and held it in 5 quarters. The position peaked at $1.21M in Q4 2015. 138 funds tracked by Wall St. Rank hold XLRN as of Q3 2016.

  • Mariner Investment Group reported no remaining Acceleron Pharma position as of Q3 2016 after selling out during the quarter.
  • Mariner Investment Group sold 27,700 Acceleron Pharma shares in Q3 2016, an estimated $941K.
  • Mariner Investment Group first reported a position in Acceleron Pharma in Q2 2015 and held it in 5 quarters.
  • Mariner Investment Group's Acceleron Pharma position peaked at $1.21M in Q4 2015.
  • 138 funds tracked by Wall St. Rank held Acceleron Pharma as of Q3 2016.

Based on Mariner Investment Group's 13F filing for Q3 2016, filed 3 Nov 2016.